BIGG

Therapeutics and COVID-19: living guideline - 16 September 2022

World Health Organization.

The WHO Therapeutics and COVID-19: living guideline contains the Organization’s most up-to-date recommendations for the use of therapeutics in the treatment of COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an online platform, an...

Janus Kinase Inhibitors/therapeutic use, COVID-19/drug therapy, Antiviral Agents/therapeutic use, Ivermectin/therapeutic use, Hydroxychloroquine/therapeutic use, Plasma/immunology, Fluvoxamine/therapeutic use, Colchicine/therapeutic use, Immunization, Passive, Receptors, Interleukin-6/therapeutic use, Lopinavir/therapeutic use, Adrenal Cortex Hormones/therapeutic use

Fulltext (primary link) Fulltext (alternative link) Fulltext (alternative link)

Australian guidelines for the clinical care of people with COVID-19 - Australian National COVID-19 Clinical Evidence Taskforce

National COVID-19 Clinical Evidence Taskforce.

This guideline aims to provide specific, patient-focused recommendations on management and care of people with suspected or confirmed COVID-19. With the exception of chemoprophylaxis for the prevention of infection in people exposed to COVID-19, the guideline does not include other interventions used in ...

Clinical Diagnosis/diagnosis, Betacoronavirus/drug effects, Coronavirus Infections/diagnosis, Pneumonia, Viral/diagnosis, Hypoxia/diagnosis, Patient Acuity, Coronavirus Infections/drug therapy, Pneumonia, Viral/drug therapy, Dexamethasone/therapeutic use, Breast Feeding, Antiviral Agents/therapeutic use, Hydroxychloroquine/therapeutic use, Colchicine/therapeutic use, Plasma/immunology, Darunavir/therapeutic use, Interferons/therapeutic use, Evidence-Based Practice/methods

Fulltext

Management of Acute and Recurrent Gout: A Clinical Practice Guideline From the American College of Physicians

Ann. intern. med; 166 (1), 2016

DESCRIPTION: The American College of Physicians (ACP) developed this guideline to present the evidence and provide clinical recommendations on the management of gout. METHODS: Using the ACP grading system, the committee based these recommendations on a systematic review of randomized, controlled trials; ...

Adrenal Cortex Hormones, Anti-Inflammatory Agents, Non-Steroidal/therapeutic use, Gout Suppressants/therapeutic use, Uric Acid/therapeutic use, Adrenocorticotropic Hormone, Colchicine/therapeutic use, Gout/diet therapy, Gout, Gout/drug therapy

Fulltext